Checkmark
Legislation watch
     

Search all years.

2021 House Bill 5262: Revise certain opioid-related drug prescription procedures

Public Act 42 of 2022

Introduced by Rep. Abdullah Hammoud (D) on August 17, 2021
To require health insurers to provide new customers a nonopioid directive form to insureds upon enrollment. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.   Official Text and Analysis.
Referred to the House Health Policy Committee on August 17, 2021
Reported in the House on November 4, 2021
With the recommendation that the substitute (H-2) be adopted and that the bill then pass.
Substitute offered by Rep. Abdullah Hammoud (D) on November 10, 2021
To replace the previous version of the bill with one that revises details but does not change the substance as previously described.
The substitute passed by voice vote in the House on November 10, 2021
Received in the Senate on December 2, 2021
Referred to the Senate Health Policy and Human Services Committee on December 2, 2021
Reported in the Senate on March 8, 2022
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Received in the House on March 10, 2022
To require health insurers to provide a nonopioid directive form to newly insured individuals upon enrollment. This is a form that indicates to prescribers and pharmacists that an individual must not be administered an opioid or offered a prescription for an opioid. See House Bill 5261.
Signed by Gov. Gretchen Whitmer on March 23, 2022

Comments